AstraZeneca PLC (AZN)

AstraZeneca's Lynparza Gets China Nod in First-Line Setting

Aurinia's Lupus Candidate Succeeds in Pivotal Study, Stock Up

Biogen's Lupus Candidate Meets Endpoint in Phase II Study

CALQUENCE Significantly Prolonged the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocytic Leukemia

Roche's Tecentriq-Chemo Combo Gets FDA Nod in First-Line NSCLC

Is AstraZeneca plc (AZN) Going to Burn These Hedge Funds?

AstraZeneca Sells Schizophrenia Drug Rights in US and Canada

REFILE-AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment